HHS Unveils AI Centralization Plan
Overview of the Initiative
On Thursday, the Department of Health and Human Services (HHS) announced its strategy to centralize and enhance the use of artificial intelligence (AI) within the agency. This initiative aligns with the broader objective of the Trump administration to reduce costs and promote technology adoption across federal agencies. HHS plans to prioritize the sharing of AI resources among its departments, establish a governance framework for new AI tools, and encourage the application of AI in public health endeavors.
Collaboration with the Private Sector
While the initial focus of this strategy is internal, HHS has indicated its intention to partner with the private sector. The agency aims to identify “priority” health conditions and issues that could be effectively addressed using AI technologies.
Context and Background
Executive Orders and Agency Responses
This new plan from HHS follows an executive order issued by President Donald Trump, along with several memos from the Office of Management and Budget that urged federal agencies to expedite their AI adoption. Various HHS divisions, such as the Food and Drug Administration (FDA), have already announced their intentions to implement AI tools. For instance, the FDA revealed earlier this week that it would leverage agentic AI for its premarket reviews. Similarly, in September, the Centers for Disease Control and Prevention (CDC) announced its plans to utilize AI for analyzing public health data.
OneHHS Strategy
Centralization and Training
HHS’s strategy, referred to as “OneHHS,” aims to centralize AI tools and resources across its divisions. The agency also plans to provide training for employees at all levels to effectively utilize AI technologies. Jim O’Neill, Deputy Secretary of HHS, emphasized the need to reduce bureaucratic obstacles, stating, “For too long, our Department has been bogged down by bureaucracy and busy-work; even the most productive public servants are mired in paperwork and process. … It’s time to tear down those barriers.”
Assessment and Governance
The internal strategy includes initial assessments of the agency’s AI capabilities, enabling HHS to evaluate the “maturity” of its AI tools. HHS will establish a governance board consisting of senior leaders from various divisions, meeting at least twice a year to streamline approvals for new AI projects, monitor existing tools, and develop risk protocols for “high-impact AI” applications. Details regarding the board’s membership have not been disclosed by HHS.
Funding and Metrics for Success
Support for Biomedical Research
HHS will allocate funding for scientific programs that incorporate AI in biomedical research and development, as well as support the implementation of AI tools for clinical decision-making. These tools aim to enhance patient care across various healthcare settings.
Goals for Public Health Improvement
The agency has identified specific metrics to evaluate the success of AI adoption in public health, including reductions in hospital readmissions, decreased sepsis mortality rates, fewer unnecessary emergency department visits, and improved outcomes for infants and mothers.
Challenges and Risks in AI Adoption
Healthcare Sector’s Hesitance
As the healthcare sector increasingly integrates AI tools, there is optimism that these technologies can address persistent challenges, such as staffing shortages and administrative burdens. However, the use of AI carries inherent risks, including the potential for inaccurate responses and biased data, which can lead to serious consequences for patients and healthcare providers.
Lack of Federal Guidance
Thus far, the industry has navigated these risks with minimal guidance from the federal government. Although a comprehensive executive order regarding AI in healthcare was signed by President Joe Biden in January, it was rescinded shortly after the Trump administration began. Despite efforts to promote AI adoption, the plans released by Trump have lacked specific healthcare details. Concurrently, the Trump administration has encouraged federal agencies, including HHS, to adopt AI technologies to achieve cost savings, even as HHS undergoes significant restructuring, including plans to reduce its workforce by 10,000 and consolidate its divisions from 28 to 15.